1. Home
  2. GLP vs RCUS Comparison

GLP vs RCUS Comparison

Compare GLP & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLP
  • RCUS
  • Stock Information
  • Founded
  • GLP 2005
  • RCUS 2015
  • Country
  • GLP United States
  • RCUS United States
  • Employees
  • GLP 5060
  • RCUS N/A
  • Industry
  • GLP Oil Refining/Marketing
  • RCUS Biotechnology: Pharmaceutical Preparations
  • Sector
  • GLP Energy
  • RCUS Health Care
  • Exchange
  • GLP Nasdaq
  • RCUS Nasdaq
  • Market Cap
  • GLP 1.7B
  • RCUS 1.4B
  • IPO Year
  • GLP 2005
  • RCUS 2018
  • Fundamental
  • Price
  • GLP $49.79
  • RCUS $15.72
  • Analyst Decision
  • GLP Strong Buy
  • RCUS Buy
  • Analyst Count
  • GLP 1
  • RCUS 12
  • Target Price
  • GLP $54.00
  • RCUS $34.50
  • AVG Volume (30 Days)
  • GLP 76.0K
  • RCUS 932.9K
  • Earning Date
  • GLP 11-08-2024
  • RCUS 11-06-2024
  • Dividend Yield
  • GLP 5.90%
  • RCUS N/A
  • EPS Growth
  • GLP N/A
  • RCUS N/A
  • EPS
  • GLP 3.26
  • RCUS N/A
  • Revenue
  • GLP $17,386,440,000.00
  • RCUS $263,000,000.00
  • Revenue This Year
  • GLP $26.21
  • RCUS $112.97
  • Revenue Next Year
  • GLP $22.37
  • RCUS N/A
  • P/E Ratio
  • GLP $15.19
  • RCUS N/A
  • Revenue Growth
  • GLP 5.31
  • RCUS 119.17
  • 52 Week Low
  • GLP $33.20
  • RCUS $13.50
  • 52 Week High
  • GLP $50.85
  • RCUS $20.31
  • Technical
  • Relative Strength Index (RSI)
  • GLP 64.02
  • RCUS 43.78
  • Support Level
  • GLP $48.20
  • RCUS $15.03
  • Resistance Level
  • GLP $49.85
  • RCUS $18.98
  • Average True Range (ATR)
  • GLP 1.13
  • RCUS 1.02
  • MACD
  • GLP 0.17
  • RCUS -0.04
  • Stochastic Oscillator
  • GLP 96.57
  • RCUS 20.07

About GLP Global Partners LP Common Units representing Limited Partner Interests

Global Partners LP is an U.S.-based limited partnership that acts as a midstream logistics and marketing company. It is mainly engaged in purchasing, selling, storing and logistics of transporting petroleum and related products. The company owns and operates and control terminal networks of refined petroleum products and renewable fuels in Massachusetts, Maine, Connecticut, Vermont, and other places. It distributes gasoline and gasoline blendstocks, distillates, residual oil, renewable fuels, crude oil, natural gas and propane to wholesalers, retailers and commercial customers. The company operates through three segments i.e. Wholesale, Gasoline Distribution and Station Operations and Commercial. It generates maximum revenue from the Wholesale segment.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: